In vitro effect of reproterol upon pulmonary, cardiac, vascular and intestinal 3',5'-monophosphate phosphodiesterase nucleoside.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D004338:Drug Combinations; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007422:Intestines / Q000201:enzymology; D008168:Lung / Q000201:enzymology; D008297:Male; D009921:Metaproterenol / Q000031:analogs & derivatives* / Q000494:pharmacology; D009130:Muscle, Smooth / Q000201:enzymology; D009131:Muscle, Smooth, Vascular / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D010446:Peptide Fragments / Q000494:pharmacology; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology
C034481:ACTH amide (1-18), Gly(1)-; D004338:Drug Combinations; D010446:Peptide Fragments; C014792:reproterol; D009921:Metaproterenol; D000324:Adrenocorticotropic Hormone; D013806:Theophylline; D015105:3',5'-Cyclic-AMP Phosphodiesterases